Eyes-closed task-free electroencephalography in clinical trials for Alzheimer's disease: An emerging method based upon brain dynamics

Alzheimer's Research and Therapy

Volumn 6, Issue 9, 2014, Pages

  Van Straaten, Elisabeth C W ^a,b   Scheltens, Philip ^c   Gouw, Alida A ^a,c   Stam, Cornelis J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Nutricia Nederland   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN REGION; CLINICAL TRIAL (TOPIC); ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EYES CLOSED TASK FREE ELECTROENCEPHALOGRAPHY; FREQUENCY ANALYSIS; HUMAN; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNAPSE;

EID: 84927945410     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-014-0086-x     Document Type: Review

References (62)

1. Berk C, Sabbagh MN: Successes and failures for drugs in late-stage development for Alzheimer's disease. Drugs Aging 2013, 30:783-792.
2. Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B, Oxford Task Force Group: Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol 2011, 95:579-593.
3. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science (NY) 2002, 298:789-791.
4. Buzsaki G, Anastassiou CA, Koch C: The origin of extracellular fields and currents - EEG, ECoG, LFP and spikes. Nat Rev Neurosci 2012, 13:407-420.
5. Whitham EM, Pope KJ, Fitzgibbon SP, Lewis T, Clark CR, Loveless S, Broberg M, Wallace A, DeLosAngeles D, Lillie P, Hardy A, Fronsko R, Pulbrook A, Willoughby JO: Scalp electrical recording during paralysis: quantitative evidence that EEG frequencies above 20 Hz are contaminated by EMG. Clin Neurophysiol 2007, 118:1877-1888.
6. Jeong J: EEG dynamics in patients with Alzheimer's disease. Clin Neurophysiol 2004, 115:1490-1505.
7. Jackson CE, Snyder PJ: Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease. Alzheimers Dement 2008, 4:S137-S143.
8. Babiloni C, Del Percio C, Lizio R, Marzano N, Infarinato F, Soricelli A, Salvatore E, Ferri R, Bonforte C, Tedeschi G, Montella P, Baglieri A, Rodriguez G, Famà F, Nobili F, Vernieri F, Ursini F, Mundi C, Frisoni GB, Rossini PM: Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment. Neurobiol Aging 2014, 35:130-142.
9. Forstl H, Sattel H, Besthorn C, Daniel S, Geiger-Kabisch C, Hentschel F, Sarochan M, Zerfass R: Longitudinal cognitive, electroencephalographic and morphological brain changes in ageing and Alzheimer's disease. Br J Psychiatry 1996, 168:280-286.
10. de Waal H, Stam CJ, de Haan W, van Straaten EC, Scheltens P, van der Flier WM: Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics. Neurobiol Aging 2012, 33:1008.e1025-1008.e1031.
11. Klass DW, Brenner RP: Electroencephalography of the elderly. J Clin Neurophysiol 1995, 12:116-131.
12. Ponomareva NV, Korovaitseva GI, Rogaev EI: EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol Aging 2008, 29:819-827.
13. de Waal H, Stam CJ, de Haan W, van Straaten EC, Blankenstein MA, Scheltens P, van der Flier WM: Alzheimer's disease patients not carrying the apolipoprotein E epsilon4 allele show more severe slowing of oscillatory brain activity. Neurobiol Aging 2013, 34:2158-2163.
14. Saletu B, Anderer P, Paulus E, Grunberger J, Wicke L, Neuhold A, Fischhof PK, Litschauer G: EEG brain mapping in diagnostic and therapeutic assessment of dementia. Alzheimer Dis Assoc Disord 1991, 5:S57-S75.
15. Muller TJ, Thome J, Chiaramonti R, Dierks T, Maurer K, Fallgatter AJ, Frolich L, Scheubeck M, Strik WK: A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1997, 247:259-263.
16. Gianotti LR, Kunig G, Lehmann D, Faber PL, Pascual-Marqui RD, Kochi K, Schreiter-Gasser U: Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease. Clin Neurophysiol 2007, 118:186-196.
17. Abuhassan K, Coyle D, Maguire LP: Investigating the neural correlates of pathological cortical networks in Alzheimer 's disease using heterogeneous neuronal models. IEEE Trans BioMed Eng 2012, 59:890-896.
18. Stam CJ, de Haan W, Daffertshofer A, Jones BF, Manshanden I, van Cappellen van Walsum AM, Montez T, Verbunt JP, de Munck JC, van Dijk BW, Berendse HW, Scheltens P: Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain 2009, 132:213-224.
19. Thal DR, Griffin WS, Braak H: Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med 2008, 12:1848-1862.
20. Adler G, Brassen S: Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients. Neuropsychobiology 2001, 43: 273-276.
21. Adler G, Brassen S, Chwalek K, Dieter B, Teufel M: Prediction of treatment response to rivastigmine in Alzheimer's dementia. J Neurol Neurosurg Psychiatry 2004, 75:292-294.
22. Balkan S, Yaras N, Mihci E, Dora B, Agar A, Yargicoglu P: Effect of donepezil on EEG spectral analysis in Alzheimer's disease. Acta Neurol Belg 2003, 103:164-169.
23. Brassen S, Adler G: Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry 2003, 36:304-308.
24. Gianotti LR, Kunig G, Faber PL, Lehmann D, Pascual-Marqui RD, Kochi K, Schreiter-Gasser U: Rivastigmine effects on EEG spectra and threedimensional LORETA functional imaging in Alzheimer's disease. Psychopharmacology (Berl) 2008, 198:323-332.
25. Kogan EA, Korczyn AD, Virchovsky RG, Klimovizky S, Treves TA, Neufeld MY: EEG changes during long-term treatment with donepezil in Alzheimer's disease patients. J Neural Transm 2001, 108:1167-1173.
26. Reeves RR, Struve FA, Patrick G: The effects of donepezil on quantitative EEG in patients with Alzheimer's disease. Clin Electroencephalogr 2002, 33:93-96.
27. Rodriguez G, Vitali P, Canfora M, Calvini P, Girtler N, De Leo C, Piccardo A, Nobili F: Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease. Clin Neurophysiol 2004, 115:39-49.
28. Rodriguez G, Vitali P, De Leo C, De Carli F, Girtler N, Nobili F: Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. Neuropsychobiology 2002, 46:49-56.
29. de Waal H, Stam CJ, Lansbergen MM, Wieggers RL, Kamphuis PJ, Scheltens P, Maestu F, van Straaten EC: The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study. PLoS One 2014, 9:e86558.
30. Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, de Waal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ: Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 2012, 31:225-236.
31. Pereda E, Quiroga RQ, Bhattacharya J: Nonlinear multivariate analysis of neurophysiological signals. Prog Neurobiol 2005, 77:1-37.
32. Uhlhaas PJ, Pipa G, Lima B, Melloni L, Neuenschwander S, Nikolic D, Singer W: Neural synchrony in cortical networks: history, concept and current status. Front Integr Neurosci 2009, 3:17.
33. Connected Brains [http://home.kpn.nl/stam7883/]
34. Koenig T, Prichep L, Dierks T, Hubl D, Wahlund LO, John ER, Jelic V: Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2005, 26:165-171.
35. Park YM, Che HJ, Im CH, Jung HT, Bae SM, Lee SH: Decreased EEG synchronization and its correlation with symptom severity in Alzheimer's disease. Neurosci Res 2008, 62:112-117.
36. Knyazeva MG, Jalili M, Brioschi A, Bourquin I, Fornari E, Hasler M, Meuli R, Maeder P, Ghika J: Topography of EEG multivariate phase synchronization in early Alzheimer 's disease. Neurobiol Aging 2010, 31:1132-1144.
37. Stam CJ, van der Made Y, Pijnenburg YA, Scheltens P: EEG synchronization in mild cognitive impairment and Alzheimer's disease. Acta Neurol Scand 2003, 108:90-96.
38. Knyazeva MG, Carmeli C, Khadivi A, Ghika J, Meuli R, Frackowiak RS: Evolution of source EEG synchronization in early Alzheimer's disease. Neurobiol Aging 2013, 34:694-705.
39. Ansari-Asl K, Senhadji L, Bellanger JJ, Wendling F: Quantitative evaluation of linear and nonlinear methods characterizing interdependencies between brain signals. Phys Rev E Stat Nonlin Soft Matter Phys 2006, 74:031916.
40. David O, Cosmelli D, Friston KJ: Evaluation of different measures of functional connectivity using a neural mass model. Neuroimage 2004, 21:659-673.
41. Quian Quiroga R, Kraskov A, Kreuz T, Grassberger P: Performance of different synchronization measures in real data: a case study on electroencephalographic signals. Phys Rev E Stat Nonlin Soft Matter Phys 2002, 65:041903.
42. Nolte G, Bai O, Wheaton L, Mari Z, Vorbach S, Hallett M: Identifying true brain interaction from EEG data using the imaginary part of coherency. Clin Neurophysiol 2004, 115:2292-2307.
43. Stam CJ, Nolte G, Daffertshofer A: Phase lag index: assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources. Hum Brain Mapp 2007, 28:1178-1193.
44. Fornari E, Maeder P, Meuli R, Ghika J, Knyazeva MG: Demyelination of superficial white matter in early Alzheimer's disease: a magnetization transfer imaging study. Neurobiol Aging 2012, 33:428.e427-428.e419.
45. Sporns O: Contributions and challenges for network models in cognitive neuroscience. Nat Neurosci 2014, 17:652-660.
46. Bullmore E, Sporns O: Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 2009, 10:186-198.
47. Stam CJ, van Straaten EC: The organization of physiological brain networks. Clin Neurophysiol 2012, 123:1067-1087.
48. Watts DJ, Strogatz SH: Collective dynamics of 'small-world' networks. Nature 1998, 393:440-442.
49. de Haan W, Pijnenburg YA, Strijers RL, van der Made Y, van der Flier WM, Scheltens P, Stam CJ: Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory. BMC Neurosci 2009, 10:101.
50. Vecchio F, Miraglia F, Marra C, Quaranta D, Vita MG, Bramanti P, Rossini PM: Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data. J Alzheimers Dis 2014, 41:113-127.
51. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA: Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 2009, 29:1860-1873.
52. de Haan W, Mott K, van Straaten EC, Scheltens P, Stam CJ: Activity dependent degeneration explains hub vulnerability in Alzheimer's disease. PLoS Comput Biol 2012, 8:e1002582.
53. van Wijk BC, Stam CJ, Daffertshofer A: Comparing brain networks of different size and connectivity density using graph theory. PLoS One 2010, 5:e13701.
54. Tijms BM, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F: Alzheimer's disease: connecting findings from graph theoretical studies of brain networks. Neurobiol Aging 2013, 34:2023-2036.
55. Stam CJ, Tewarie P, Van Dellen E, van Straaten EC, Hillebrand A, Van Mieghem P: The trees and the forest: characterization of complex brain networks with minimum spanning trees. Int J Psychophysiol 2014, 92:129-138.
56. Ciftci K: Minimum spanning tree reflects the alterations of the default mode network during Alzheimer's disease. Ann Biomed Eng 2011, 39:1493-1504.
57. Boersma M, Smit DJ, Boomsma DI, De Geus EJ, de Waal HA D-v, Stam CJ: Growing trees in child brains: graph theoretical analysis of electroencephalography-derived minimum spanning tree in 5- and 7-year-old children reflects brain maturation. Brain Connect 2013, 3:50-60.
58. van Diessen E, Otte WM, Braun KP, Stam CJ, Jansen FE: Does sleep deprivation alter functional EEG networks in children with focal epilepsy? Front Syst Neurosci 2014, 8:67.
59. Gephi [https://gephi.org/]
60. Broich K, Weiergraber M, Hampel H: Biomarkers in clinical trials for neurodegenerative diseases: regulatory perspectives and requirements. Prog Neurobiol 2011, 95:498-500.
61. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC: Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001, 58:1395-1402.
62. Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frolich L, Riepe MW, Dodel R, Leyhe T, Bertram L, Hoffmann W, Faltraco F, German Task Force on Alzheimer's Disease (GTF-AD): The future of Alzheimer's disease: the next 0 years. Prog Neurobiol 2011, 95:718-728.